RNA Revenue Flow
Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
- 2026-06-30: Revenue $3.00M; Research and development $15.34M; Operating expenses $25.62M; Net income -$20.19M.
- 2026-03-31: Revenue $19.64M; Research and development $16.66M; Operating expenses $36.91M; Net income -$16.63M.
- 2025-06-30: Revenue $3.85M; Research and development $13.29M; Operating expenses $16.71M; Net income -$12.88M.
- 2025-03-31: Revenue $1.57M; Research and development $6.94M; Operating expenses $9.03M; Net income -$7.45M.
Type Of Arrangement
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown
Revenue and expense 3 month
| Period end | Revenue | Research and development | Operating expenses | Net income |
|---|---|---|---|---|
| 2026-06-30 | $3.00M | $15.34M | $25.62M | -$20.19M |
| 2026-03-31 | $19.64M | $16.66M | $36.91M | -$16.63M |
| 2025-06-30 | $3.85M | $13.29M | $16.71M | -$12.88M |
| 2025-03-31 | $1.57M | $6.94M | $9.03M | -$7.45M |
Revenue and expense 6 month
| Period end | Revenue | Research and development | Operating expenses | Net income |
|---|---|---|---|---|
| 2026-06-30 | $22.64M | $32.00M | $62.54M | -$36.82M |
| 2025-06-30 | $5.42M | $20.23M | $25.74M | -$20.33M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |